RECENT NEWS

LDC-backed RDi, a leader in data driven, automated self-sampling kits for healthcare, is pleased to announce the successful acquisition of Inicio Health, a pioneering force in healthcare interoperability, automation and AI solutions.

A simple at-home saliva test may be more accurate at detecting prostate cancer than the current prostate-specific antigen (PSA) blood test, new National Institute for Health and Care Research (NIHR)-funded research suggests.

Patients with advanced skin cancer in England are set to be fast-tracked into trials of a new cancer vaccine, following the expansion of a world-leading NHS programme.

Sphere Bio, a leading provider of picodroplet-based microfluidics for functional single-cell analysis and isolation, has announced a significant expansion of its Asia Pacific distributor network.

Antibiotic resistance tends to stabilise over time, according to a recent study, which also showed use of antibiotics was weakly associated with resistance, indicating additional factors may be at play.

Source BioScience has announced the acquisition of Cambridge Clinical Laboratories (CCL), a leading Cambridge-based provider of clinical, personalised healthcare testing services.

Clean Cells, part of the Clean Biologics group, a leading biopharmaceutical quality control services provider specialising in biologics GMP testing, has announced the strategic acquisition of Karyologic Inc, a specialised karyotyping services company based in Durham, North Carolina, USA.

Analytik Jena is expanding its liquid handling portfolio with a new 1536-tip tray for the CyBio Well vario. In combination with the appropriate pipetting head, this consumable enables parallel pipetting in 1,536 channels.

The World Health Organization (WHO) has confirmed the successful redesignation of the Medicines and Healthcare products Regulatory Agency (MHRA) Science and Research group as one of its Collaborating Centres for the Standardisation and Evaluation of Biologicals for the next four years.

Sphere Bio has launched the Cyto-Cellect Human IgG Kappa and Viability Assay Kit, the first multiplexed assay developed specifically for the company’s new Cyto-Mine Chroma platform.

Scientists have taken an important step toward the development of a potential new treatment for treating Shiga toxin-producing E. coli (STEC), which is associated with severe food poisoning.

Lab Innovations, the UK’s meeting place for laboratory professionals across the scientific spectrum, won the Award for Best Trade Show under 5000 square metres at the Exhibition News award ceremony on 31 March 2025.

The Serious Hazards of Transfusion Scheme has confirmed arrangement for two for forthcoming SHOT Meet the Expert webinars, the details of which can be found below.

Peninsula Pathology Network, which brings together pathology services at five sites in Devon, Cornwall, and the Isles of Scilly, today announces a partnership with UK cloud, connectivity, communications, and cyber security provider, Exponential-e to implement a secure private cloud environment.

Bio-Techne has announced an expansion of the longstanding partnership between its spatial biology brand, Advanced Cell Diagnostics (ACD), and Leica Biosystems.

The UK Health Security Agency (UKHSA) is launching a call for evidence to help shape the next 5-year Tuberculosis (TB) National Action Plan for England, which will run from 2026 to 2031. The latest data for England show that TB rates are rising, and TB epidemiology is changing.

Biotia has announced a joint development agreement with Mayo Clinic to propel precision medicine in infectious disease diagnostics.

The British In Vitro Diagnostics Association (BIVDA) - along with leading industry and health charities - has launched a new policy declaration that highlights the value of community diagnostics and their role in a future neighbourhood NHS.

Digital pathology firm Diagnexia and Stratipath AB, a pioneer in AI-based cancer diagnostics, have announced a strategic partnership to bring Stratipath Breast, an AI-based prognostic risk profiling tool for invasive breast cancer, to pathology laboratories, hospitals, and healthcare providers across the UK and Europe.

The Association for Molecular Pathology and pathologist Michael Laposata MD PhD, have announced a favourable ruling in their lawsuit against the U.S. Food and Drug Administration over the regulation of laboratory-developed test (LDT) procedures.